Abstract
SAMUELSSON'S group1,2 showed that human platelets convert arachidonic acid and prostaglandin (PG) endoperoxides3 to thromboxane A2 (TXA2). TXA2 strongly aggregates platelets1 and contracts vascular strips1,4,5. Vane's group5,6 has identified TXA2 synthetase in platelet microsomes—this enzyme generates TXA2 from PG endoperoxides. Aspirin-like drugs inhibit generation of PGs (refs 7, 8) and TXA2 (ref. 9) in platelets at the early stage of cyclooxygenation of arachidonic acid10,11. It is through this activity that aspirin, indomethacin, naproxen and other acidic anti-inflammatory drugs are anti-aggregatory11,12—they have little or no effect on generation of TXA2 from PG endoperoxides6. We report here that the non-acidic anti-inflammatory compound 2-isopropyl-3-nicotinyl-indole (L 8027) (refs 13, 14) is a selective TXA2, synthetase inhibitor in platelets and a potent anti-aggregatory agent.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hamberg, M., Svensson, J. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 72, 2994–2998 (1975).
Hamberg, M., Svensson, J. & Samuelsson, B. Advances in Prostaglandin and Thromboxane Research 1 (eds Samuelsson, B. & Paoletti, R) 19–27 (Raven, New York, 1976).
Hamberg, M. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 70, 899–903 (1973).
Svensson, J., Hamberg, M. & Samuelsson, B. Acta physiol. scand. 94, 222–228 (1975).
Needleman, P. et al. Nature 261, 558–560 (1976).
Moncada, S., Needleman, P., Bunting, S. & Vane, J. R. Prostaglandins 12, 323–336 (1976).
Vane, J. R. Nature new Biol. 231, 233–235 (1971).
Smith, J. B. & Willis, A. L. Nature new Biol. 231, 235–237 (1971).
Green, K., Hamberg, M. & Samuelsson, B. Advances in Prostaglandin and Thromboxane Research 1 (eds B. Samuelsson, B. & Paoletti, R.) 47–58 (Raven, New York, 1976).
Flower, R. J. Pharmac. Rev. 26, 33–67 (1974).
Smith, J. B. & Macfarlane, D. E. The Prostaglandins 2 (ed. Ramwell, P. W.) 293–343 (Plenum, New York, 1974).
Mustard, J. F. & Packham, M. A. Drugs 9, 19–76 (1975).
Deby, C., Descamps, M., Binon, F. & Bacq, Z. M. C. r. Seanc. Soc. Biol. 165, 2465–2468 (1971).
Colot, M. et al. Thérapie 28, 775–798 (1973).
Takeguchi, C., Kohno, E. & Sih, C. J. Biochemistry 10, 2372–2376 (1971).
Gryglewski, R. J. Prostaglandin Synthetase Inhibitors (eds Robinson, H. J. & Vane, J. R.) 33–52 (Raven, New York, 1974).
Bergström, S., Danielsson, H. & Samuelsson, B. Biochim. biophys. Acta 90, 170–180 (1964).
Lands, W. E. M., Lee, P. & Smith, W. Ann. N. Y. Acad. Sci. 180, 107–122 (1971).
Bunting, S. Moncada, S. & Vane, J. R. Proc. Br. pharmac. Soc. April, 1976. p.48.
Piper, P. J. & Vane, J. R. Nature 223, 29–35 (1969).
Vane, J. R. Br. J. Pharmac. 12, 344–349 (1957).
Regoli, D. & Vane, J. R. Br. J. Pharmac. 23, 351–359 (1964).
Vane, J. R. Br. J. Pharmac. 23, 369–373 (1964).
Gilmore, N., Vane, J. R. & Wyllie, J. H. Nature 218, 1135–1140 (1968).
Bundy, G. L. Tetrahedron Lett. 24, 1957–1960 (1975).
Malmsten, C. Life Sci. 18, 169–176 (1976).
Moncada, S., Gryglewski, R., Bunting, S. & Vane, J. R. Nature 263, 663–665 (1976).
Gryglewski, R., Bunting, S., Moncada, S., Flower, R. J. & Vane, J. R. Prostaglandins 12, 685–713 (1976).
Moncada, S., Gryglewski, R., Bunting, S. & Vane, J. R. Prostaglandins 12, 715–733 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GRYGLEWSKI, R., ZMUDA, A., KORBUT, R. et al. Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature 267, 627–628 (1977). https://doi.org/10.1038/267627a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/267627a0
This article is cited by
-
3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase
Agents and Actions (1981)
-
9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets
Nature (1978)
-
In vivo method for quantitation of anti-platelet potency of drugs
Naunyn-Schmiedeberg's Archives of Pharmacology (1978)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.